Publications

Check our publications

Publications

Since 2007 GENVIP has published more than 430 publications

Showing 0 de
0 publications
highlight
Reset everything

Año

Reset

Journal

Reset
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters appied:
Tag
close icon
Sort by
IMPACT OF ROTAVIRUS VACCINATION ON CHILDHOOD HOSPITALIZATIONS FOR SEIZURES: HETEROLOGOUS OR UNFORESEEN DIRECT VACCINE EFFECTS?
Salas, A; Pardo-Seco, J; Cebey-Lopez, M; Martinon-Martinez, JM; Gomez-Rial, J; Curras-Tuala, MJ; Pischedda, S; Barral-Arca, R; Justicia-Grande, A; Rivero-Calle, I
Journal:
Vaccine
Publicación independiente
Impact factor
3.143
Q2
Year:
2019
Doi:
https://doi.org/10.1016/j.vaccine.2019.04.086
IDENTIFICATION OF REGULATORY VARIANTS ASSOCIATED WITH GENETIC SUSCEPTIBILITY TO MENINGOCOCCAL DISEASE
Lisa Borghini, Eileen Png, Alexander Binder, Victoria J. Wright, Ellie Pinnock, Ronald de Groot, Jan Hazelzet, Marieke Emonts, Michiel Van der Flier, Luregn J. Schlapbach, Suzanne Anderson, Fatou Secka, Antonio Salas, Colin Fink, Enitan D. Carrol, Andrew J. Pollard, Lachlan J. Coin, Taco W. Kuijpers, Federico Martinon-Torres, Werner Zenz, Michael Levin, Martin L. Hibberd, Sonia Davila & EUCLIDS consortium
Journal:
Scientific Reports
Publicación independiente
Impact factor
3.998
Q1
Year:
2019
Doi:
https://doi.org/10.1038/s41598-019-43292-6
DEL GENOMA DE UN PATÓGENO A UNA VACUNA EFECTIVA: LA VACUNA DE CUATRO COMPONENTES FRENTE A LOS MENINGOCOCOS DEL SEROGRUPO B
Raquel Abad, Federico Martinón-Torres, María Elena Santolava, Angelika Banzhoff, Carmen González-Inchausti, María Gabriela Graña, Julio A. Vázquez
Journal:
Rev Esp Quimioter.
Publicación independiente
Impact factor
1.132
Q4
Year:
2019
Doi:
EPIDEMIOLOGICAL AND CLINICAL FEATURES OF KAWASAKI DISEASE IN SPAIN OVER 5 YEARS AND RISK FACTORS FOR ANEURYSM DEVELOPMENT. (2011-2016): KAWA-RACE STUDY GROUP
Elisa Fernandez-CookeI, Ana Barrios Tasco,, Judith Sa´nchez-Manubens, Jordi Antón, Carlos Daniel Grasa LozanoI, Javier Aracil Santos, Enrique Villalobos Pinto,, Daniel Clemente Garulo, Beatriz Mercader Rodríguez, Matilde Bustillo Alonso, Esmeralda Nuñez Cuadros, Maria Luisa Navarro Gómez, Sara Domínguez Rodríguez, Cristina Calvo, on behalf of the KAWA-RACE study group (Martinón-Torres, F; Rivero Calle, I, Justicia Grande, A)
Journal:
PLOS ONE,
Publicación independiente
Impact factor
2.740
Q2
Year:
2019
Doi:
OMIC TECHNOLOGIES AND VACCINE DEVELOPMENT: FROM THE IDENTIFICATION OF VULNERABLE INDIVIDUALS TO THE FORMULATION OF INVULNERABLE VACCI
Nicola Cotugno , Alessandra Ruggiero , Veronica Santilli, Emma Concetta Manno, Salvatore Rocca , Sonia Zicari, Donato Amodio , Manuela Colucci , Paolo Rossi, Ofer Levy, Federico Martinon-Torres , Andrew J. Pollard, and Paolo Palma
Journal:
Journal of Immunology Research
Publicación independiente
Impact factor
3.327
Q3
Year:
2019
Doi:
https://doi.org/10.1155/2019/8732191
FURTHER CONSIDERATIONS ON ROTAVIRUS VACCINATION AND SEIZURE-RELATED HOSPITALIZATION RATES
Jose Gómez-Rial, Sonia Sánchez-Batá, Irene Rivero-Calle, Jacobo Pardo-Seco, José María Martinón-Martínez, Antonio Salas, Federico Martinón-Torres,
Journal:
Infection and Drug Resistance
Publicación independiente
Impact factor
2.984
Q1
Year:
2019
Doi:
https://doi.org/10.2147/IDR.S208756
SAFETY AND IMMUNOGENICITY OF PNEUMOCOCCAL CONJUGATE VACCINES IN PRETERM INFANTS
Carolina López-Sanguos, Irene Rivero Calle, Carmen Rodriguez Tenreiro, Peter Francis Raguindin and Federico Martinón-Torres
Journal:
Expert Opin Drug Saf
Publicación independiente
Impact factor
3.383
Q2
Year:
2019
Doi:
https://doi.org/10.1080/14740338.2019.1597849
¿QUÉ HEMOS APRENDIDO SOBRE ROTAVIRUS EN ESPAÑA EN LOS ÚLTIMOS 10 AÑOS?
Javier Díez-Domingo, María Garcés-Sánchez, Francisco Giménez-Sánchez, Javier Colomina-Rodríguez, Federico Martinón-Torres
Journal:
An Pediatr (Barc)
Publicación independiente
Impact factor
1.313
Q3
Year:
2019
Doi:
https://doi.org/10.1016/j.anpedi.2019.01.024
LIFESTYLE AND COMORBID CONDITIONS AS RISK FACTORS FOR COMMUNITY-ACQUIRED PNEUMONIA IN OUTPATIENT ADULTS (NEUMO-ES-RISK project)
Irene Rivero-Calle, Miriam Cebey-López, Jacobo Pardo-Seco, José Yuste, Esther Redondo, Diego A Vargas, Enrique Mascarós,Jose Luis Díaz-Maroto, Manuel Linares-Rufo, Isabel Jimeno, Angel Gil, Jesus Molina, Daniel Ocaña,Federico Martinón-Torres, on behalf of NEUMOEXPERTOS group
Journal:
BMJ Open Respir Res
Publicación independiente
Impact factor
Year:
2019
Doi:
https://doi.org/10.1136/bmjresp-2018-000359
EFFICACY, IMMUNOGENICITY, AND SAFETY OF A QUADRIVALENT INACTIVATED INFLUENZA VACCINE IN CHILDREN AGED 6–35 MONTHS: A MULTI-SEASON RANDOMISED PLACEBO-CONTROLLED TRIAL IN THE NORTHERN AND SOUTHERN HEMISPHERES
Stephanie Pepin, Martin Dupuy, Charissa Fay Corazon Borja-Tabora, May Montellanoc, Lulu Bravo, Jaime Santos, Jo-Anne de Castro, Doris Maribel Rivera-Medina, Clare Cutland, Miguel Ariza, Javier Diez-Domingo, Celia Diaz Gonzalez, Federico Martinón-Torres, Efimia Papadopoulou-Alataki, Maria Theodoriadou, Marie Pierre Kazek-Duret, Sanjay Gurunathan, Iris De Bruijn, for the GQM05 Study Group
Journal:
Vaccine
Publicación independiente
Impact factor
3.143
Q2
Year:
2019
Doi:
https://doi.org/10.1016/j.vaccine.2018.11.074
ROTAVIRUS INFECTION BEYOND THE GUT
José Gómez-Rial, Sonia Sánchez-Batán, Irene Rivero-Calle, Jacobo Pardo-Seco, José María Martinón-Martínez, Antonio Salas, Federico Martinón-Torres
Journal:
Infection and Drug Resistance
Publicación independiente
Impact factor
2.984
Q2
Year:
2019
Doi:
https://doi.org/10.2147/IDR.S186404
IMPLEMENTING UNIVERSAL VARICELLA VACCINATION IN EUROPE: THE PATH FORWARD
Vana Spoulou, Sophie Alain, Giovanni Gabutti, Carlo Giaquinto, Johannes Liese, Federico Martinon-Torres and Timo Vesikari
Journal:
Pediatric Infect Dis J
Publicación independiente
Impact factor
2.126
Q2
Year:
2019
Doi:
https://doi.org/10.1097/INF.0000000000002233
Descripción de la gripe B en las epidemias estacionales de España
Raúl Ortiz de Lejarazu, Javier Diez Domingo, Ángel Gil de Miguel, Federico Martinón-Torres, Carlos Guzmán Quilo, José María Guillén, Blanca Piedrafita, Esther Redondo Marguello
Journal:
Rev, Esp. Quimioterapia
Publicación independiente
Impact factor
1.132
Q4
Year:
2018
Doi:
EVALUATION OF A HEXAVALENT-PENTAVALENT-HEXAVALENT INFANT PRIMARY VACCINATION SERIESFOLLOWED BY A PENTAVALENT BOOSTER VACCINE IN HEALTHY INFANTS AND TODDLERS
Federico Martinόn-Torres, Javier Diez-Domingo, Emmanuel Feroldi, Emilia Jordanov, Siham B’Chir, and Xavier Da Costa, Hospital Clinico Universitario de Santiago de Compostela, Spain;FISABIO-Public Health,Valencia, Spain; Sanofi Pasteur, France; Sanofi Pasteur, USA
Journal:
Pediatric Infect Dis J
Publicación independiente
Impact factor
2.126
Q2
Year:
2019
Doi:
https://doi.org/10.1097/INF.0000000000002231
ANAMNESTIC IMMUNE RESPONSE AND SAFETY OF AN INACTIVATED QUADRIVALENT INFLUENZA VACCINE IN PRIMED VERSUS VACCINE-NAÏVE CHILDREN
Claeys C, Chandrasekaran V, García-Sicilia J, Prymula R, Díez-Domingo J, Brzostek J, Marès-Bermúdez J, Martinón-Torres, Pollard AJ, Růžková R, Martinez AC, Ulied A, Valdivieso MM, Faust SN, Snape MD, Friel D, Ollinger T, Soni J, Schuind A, Li P, Innis BL, Jain VK.
Journal:
Pediatric Infect Dis J
Publicación independiente
Impact factor
2.126
Q2
Year:
2018
Doi:
https://doi.org/10.1097/INF.0000000000002217
ADULT COMMUNITY ACQUIRED PNEUMONIA VACCINATION: 2018 UPDATE OF THE POSITIONING OF THE PNEUMONIA PREVENTION EXPERT GROUP
Redondo E, Rivero-Calle I, Vargas DA, Mascarós E, Díaz-Maroto JL, Linares M, Gil A, Molina J, Jimeno I, Ocaña D, Yuste JE, Martinón-Torres F, en nombre de Neumoexpertos en Prevención
Journal:
Semergen
Publicación independiente
Impact factor
Year:
2018
Doi:
https://doi.org/10.1016/j.semerg.2018.09.005
KAWASAKI DISEASE IN INFANTS 3 MONTHS OF AGE AND YOUNGER: A MULTICENTRE SPANISH STUDY
Grasa CD, Fernandez-Cooke E, Sánchzez-Manubens J, Antón J, Crespo D, García M, López A, Lirola Cruz MJ, Díaz-Delgado de la Peña r, Calvo C, Spanish network for the study of Kawasaki disease. KAWA-RACE (Martinón-Torres F)
Journal:
Ann Rheum Dis
Publicación independiente
Impact factor
16.102
Q1
Year:
2018
Doi:
PRIORITY NEEDS FOR CONDUCTING PANDEMIC-RELEVANT CLINICAL RESERACH WITH CHILDREN IN EUROPE: A CONSENSUS STUDY WITH PEDIATRIC CLINICIAN-RESEARCHERS.
Micaela Gal, Nina Gobat, Nicholas A. Francis, Kerenza Hood, Christopher C. Butler, Julia Bielicki, Pieter L. Fraaij, Mike Sharland, Jessica Jarvis, Annemarie M.C. van Rossum, Terho Heikkinen, Federico Martinon-Torres, Jethro Herberg, Angela Watkins, Steve A.R. Webb, Ronnie Moore, Prasanth Sukumar, and Alistair Nichol
Journal:
Pediatric Infect Dis J
Publicación independiente
Impact factor
2.126
Q2
Year:
2018
Doi:
https://doi.org/10.1097/INF.0000000000002204
DIAGNOSIS OF KAWASAKI DISEASE. USING A MINIMAL WHOLE-BLOOD GENE EXPRESSION SIGNATURE
Victoria J.Wright, Jethro A. Herberg,Myrsini Kaforou, Chisato Shimizu, Hariklia Eleftherohorinou, Hannah Shailes, Anouk M. Barendregt, Stephanie Menikou, Stuart Gormley, Maurice Berk, Long Truong Hoang, Adriana H. Tremoulet,John T. Kanegaye, Lachlan J. M. Coin, Mary P. Glodé, Martin Hibberd, TacoW. Kuijpers, Clive J. Hoggart, Jane C. Burns, Michael Levin, FRCPCH; for the Immunopathology of Respiratory, Inflammatory and Infectious Disease Study (IRIS) Consortium and the Pediatric; Emergency Medicine Kawasaki Disease Research Group (PEMKDRG)
Journal:
JAMA
Publicación independiente
Impact factor
45.540
Q1
Year:
2018
Doi:
CRITERIA HETEROGENEITY IN THE DIAGNOSIS OF ACUTE BRONCHIOLITIS IN SPAIN
Alfredo Cano-Garcinuño, Manuel Praena-Crespo, Isabel Mora-Gandarilla, Ignacio Carvajal-Urueña, María Teresa Callén-Blecua, Águeda García-Merino, Grupo de Expertos para el Diagnóstico de la Bronquiolitis (Martinon-Torres, F)
Journal:
An Ped
Publicación independiente
Impact factor
1.313
Q3
Year:
2018
Doi:
PAEDIATRIC RESEARCH IN SPAIN: CHALLENGES AND PRIORITIES.INVEST-AEP Platform
Cristina Calvo, Talía Sainz, Pilar Codoner-Franch, Begona Santiago,M. Luz García-García, César García Vera, M. Angeles Munoz-Fernandez,Antonio Pérez-Martínez, Irene Rivero, Cristina Fernandez Pérez,Asunción Mejías, Federico Martinón-Torres, Fernando Cabanas, Plataforma INVEST-AEP
Journal:
An Pediatr (Barc)
Publicación independiente
Impact factor
1.313
Q3
Year:
2018
Doi:
https://doi.org/10.1016/j.anpedi.2018.09.001
INMUNOGENICITY AND SAFETY OF MEASLES-MUMP-RUBELLA VACCINE AT TWO POTENCY ADMINISTERED TO HEALTHY CHILDREN AGED 12-15 MONTHS:A PHASE III, RANDOMIZED, NON-INFERIORITY TRIAL
Ahonen, Anitta; Berry, Andrea; Chatterjee,Archana; Clifford, Robert; Diaz Perez, Clemente; Diez-Domingo, Javier; Haney, Byron; Harrison, Christopher J;Kerdpanich, Angkool Phirangkul; Lee, Jimmy KF; Leonardi, Michael; Martinón-Torres, Federico; Miranda,Mariano; Perez Porcuna, Xavier Maria; Phongsamart, Wanatpreeya; Sharifah Huda, Engku Alwi; Toh, Teck-Hock; Twiggs, Jerry; Ulied Arminana, Angels; Varman, Meera; Zissman, Edward. GSK Vaccinesstaff: Caplanusi, Adrian; Carryn, Stephane; Henry, Ouzama; Povey, Michael.
Journal:
Vaccine
Publicación independiente
Impact factor
3.143
Q2
Year:
2018
Doi:
MENINGOCOCCAL B VACCINE IMMUNOGENICITY IN CHILDREN WITH DEFECTS IN COMPLEMENT AND SPLENIC FUNCTION
Federico Martinón-Torres, Ewa Bernatowska, Anna Shcherbina, Susanna Esposito, Leszek Szenborn, Magda Campins Marti, Stephen Hughes, Saul N. Faust, Luis I. Gonzalez-Granado, Ly-Mee Yu, Diego D’Agostino, Marco Calabresi, Daniela Toneatto, Matthew D. Snape
Journal:
Pediatrics
Publicación independiente
Impact factor
5.359
Q1
Year:
2018
Doi:
https://doi.org/10.1542/peds.2017-4250
MORTALITY AND MORBIDITY IN COMMUNITY-ACQUIRED SEPSIS IN EUROPEAN PEDIATRIC INTENSIVE CARE UNITS: A PROSPECTIVE COHORT STUDY FROM THE EUROPEAN CHILDHOOD LIFE-THREATENING INFECTIOUS DISEASE STUDY (EUCLIDS)
Navin P. Boeddha, Luregn J. Schlapbach, Gertjan J. Driessen, Jethro A. Herberg, Irene Rivero-Calle, Miriam Cebey-López, Daniela S. Klobassa, Ria Philipsen, Ronald de Groot, David P. Inwald, Simon Nadel, Stéphane Paulus, Eleanor Pinnock, Fatou Secka, Suzanne T. Anderson, Rachel S. Agbeko, Christoph Berger, Colin G. Fink, Enitan D. Carrol, Werner Zenz, Michael Levin, Michiel van der Flier, Federico Martinón-Torres, Jan A. Hazelzet, Marieke Emonts and on behalf of the EUCLIDS consortium
Journal:
Critical Care
Publicación independiente
Impact factor
6.407
Q1
Year:
2018
Doi:
https://doi.org/10.1186/s13054-018-2052-7
No results found.
¿Dónde se esconde el virus respiratorio sincitial?
Martinón-Torres F, González-Barcala FJ
Doi:
Arch Bronconeumol
Factor de impacto:
Q2
Doi:
YEAR-TO-YEAR VARIATION IN ATTACK RATES COULD RESULT IN UNDERPOWERED RESPIRATORY SYNCYTIAL VIRUS VACCINE EFFICACY TRIALS
Billard MN, Wildenbeest J, Bont LJ, Nair H, McCracken JP, Oude Rengerink K; RESCEU Investigators (Martinón-Torres F)
Doi:
J Clin Epidemiol
Factor de impacto:
Q1
Doi:
COST-EFFECTIVENESS OF RESPIRATORY SYNCYTIAL VIRUS DISEASE PREVENTION STRATEGIES: MATERNAL VACCINE VERSUS SEASONAL OR YEAR-ROUND MONOCLONAL ANTIBODY PROGRAM IN NORWEGIAN CHILDREN
Li X, Bilcke J, Vázquez Fernández L, Bont L, Willem L, Wisløff T, Jit M, Beutels P; REspiratory Syncytial virus Consortium in EUrope (RESCEU) Investigators. (martinón-Torres F)
Doi:
J Infect Dis
Factor de impacto:
Q1
Doi:
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II TRIAL TO EXPLORE THE EFFECTS OF A GABAA-Α5 NAM (BASMISANIL) ON INTELLECTUAL DISABILITY ASSOCIATED WITH DOWN SYNDROME
Goeldner C, Kishnani PS, Skotko BG, Casero JL, Hipp JF, Derks M, Hernandez MC, Khwaja O, Lennon-Chrimes S, Noeldeke J, Pellicer S, Squassante L, Visootsak J, Wandel C, Fontoura P, d'Ardhuy XL; Clematis Study Group (Martinón-Torres F)
Doi:
J Neurodev Disord
Factor de impacto:
Q2
Doi:
PERFORMANCE ASSESSMENT OF A RAPID MOLECULAR RESPIRATORY SYNCYTIAL VIRUS POINT-OF-CARE TEST: A PROSPECTIVE COMMUNITY STUDY IN OLDER ADULTS
Zuurbier RP, Korsten K, Verheij TJM, Butler C, Adriaenssens N, Coenen S, Gruselle O, Vantomme V, van Houten MA, Bont LJ, Wildenbeest JG; REspiratory Syncytial Virus Consortium in EUrope (RESCEU) Investigators. (Martinón-Torres F)
Doi:
J Infect Dis
Factor de impacto:
Q1
Doi:
RAPID VIRAL TESTING AND ANTIBIOTIC PRESCRIPTION IN FEBRILE CHILDREN WITH RESPIRATORY SYMPTOMS VISITING EMERGENCY DEPARTMENTS IN EUROPE
Tan CD, Hagedoorn NN, Dewez JE, Borensztajn DM, von Both U, Carrol ED, Emonts M, van der Flier M, de Groot R, Herberg J, Kohlmaier B, Levin M, Lim E, Maconochie IK, Martinon-Torres F, Nijman RG, Pokorn M, Rivero-Calle I, Strle F, Tsolia M, Vermont CL, Yeung S, Zachariasse JM, Zenz W, Zavadska D, Moll HA; PERFORM Consortium
Doi:
Pediatr Infect Dis J
Factor de impacto:
Q4
Doi:
Pediatric vaccination against COVID-19 and despite COVID-19
Martinón-Torres F
Doi:
An Pediatr (Engl Ed)
Factor de impacto:
Q4
Doi:
A SYSTEMATIC REVIEW OF EUROPEAN CLINICAL PRACTICE GUIDELINES FOR RESPIRATORY SYNCYTIAL VIRUS PROPHYLAXIS
Reeves RM, van Wijhe M, Lehtonen T, Stona L, Teirlinck AC, Vazquez Fernandez L, Li Y, Osei-Yeboah R, Fischer TK, Heikkinen T, van Boven M, Bøås H, Donà D, Barbieri E, Campbell H; RESCEU Investigators. (Martinón-Torres F)
Doi:
J Infect Dis
Factor de impacto:
Q1
Doi:
EQUITY IN VACCINATION POLICIES TO OVERCOME SOCIAL DEPRIVATION AS A RISK FACTOR FOR INVASIVE MENINGOCOCCAL DISEASE.
Taha MK, Martinon-Torres F, Köllges R, Bonanni P, Safadi MAP, Booy R, Smith V, Garcia S, Bekkat-Berkani R, Abitbol V
Doi:
Expert Rev Vaccines
Factor de impacto:
Q2
Doi:
COVIDPHY: A TOOL FOR PHYLOGEOGRAPHIC ANALYSIS OF SARS-COV-2 VARIATION
Bello X, Pardo-Seco J, Gómez-Carballa A, Weissensteiner H, Martinón-Torres F, Salas A
Doi:
Environ Res
Factor de impacto:
Q1
Doi:
A STRATEGY TARGETING MONOCYTE-MACROPHAGE DIFFERENTIATION TO AVOID PULMONARY COMPLICATIONS IN SARS-COV2 INFECTION
J.Gómez-Rial, F.Martinón-Torres
Clin Immunol
Factor de impacto:
Q2
Doi:
MAPPING GENOME VARIATION OF SARS-COV-2 WORLDWIDE HIGHLIGHTS THE IMPACT OF COVID-19 SUPER-SPREADERS
Alberto Gómez-Carballa, Xabier Bello, Jacobo Pardo-Seco, Federico Martinón-Torres, Antonio Salas
bioRxiv
Factor de impacto:
Q1
Doi:
CLINICAL CHARACTERISTICS OF 58 CHILDREN WITH A PEDIATRIC INFLAMMATORY MULTISYSTEM SYNDROME TEMPORALLY ASSOCIATED WITH SARS-COV-2
Elizabeth Whittaker; Alasdair Bamford; Julia Kenny; Myrsini Kaforou; Christine E. Jones; Priyen Shah; Padmanabhan Ramnarayan; Alain Fraisse; Owen Miller; Patrick Davies; Filip Kucera; Joe Brierley; Marilyn McDougall; Michael Carter; Adriana Tremoulet; Chisato Shimizu Jethro Herberg; Jane C. Burns; Hermione Lyall; Michael Levin; for the PIMS-TS Study Group and EUCLIDS and PERFORM Consortia (Federico Martinón-Torres)
JAMA
Factor de impacto:
Q1
Doi:
RNA-SEQ DATA-MINING ALLOWS THE DISCOVERY OF TWO LONG NON-CODING RNA BIOMARKERS OF VIRAL INFECTION IN HUMANS
Ruth Barral-Arca, Alberto Gómez-Carballa, Miriam Cebey-López, María José Currás-Tuala, Sara Pischedda, Sandra Viz-Lasheras, Xabier Bello, Federico Martinón-Torres and Antonio Salas
International J Molecular Sciences
Factor de impacto:
Q1
Doi:
COST OF RESPIRATORY SYNCYTIAL VIRUS-ASSOCIATED ACUTE LOWER RESPIRATORY INFECTION MANAGEMENT IN YOUNG CHILDREN AT THE REGIONAL AND GLOBAL LEVEL: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Zhang S, Akmar LZ, Bailey F, Rath BA, Alchikh M, Schweiger B, Lucero MG, Nillos LT, Kyaw MH, Kieffer A, Tong S, Campbell H, Beutels P, Nair H; RESCEU Investigators
J Infect Dis.
Factor de impacto:
Q1
Doi:
IMMUNOLOGICAL AND INFLAMMATORY BIOMARKERS OF SUSCEPTIBILITY AND SEVERITY IN ADULT RESPIRATORY SYNCYTIAL VIRUS INFECTIONS.
Wiseman DJ, Thwaites RS, Drysdale SB, Janet S, Donaldson GC, Wedzicha JA, Openshaw PJ; RESCEU Investigators
J Infect Dis.
Factor de impacto:
Q1
Doi:
LOW SENSITIVITY OF BINAXNOW RSV IN INFANTS.
Zuurbier RP, Bont LJ, Langedijk AC, Hamer M, Korsten K, Drysdale SB, Snape MD, Robinson H, Pollard AJ, Martinón-Torres F, Rodríguez-Tenreiro Sánchez C, Gómez-Carballa A, Dacosta-Urbieta AI, Heikkinen T, Cunningham S, van Houten MA, Wildenbeest JG; RESCEU Investigators .
J Infect Dis.
Factor de impacto:
Q1
Doi:
PROTECTING THE MOST VULNERABLE AGE GROUP: A REVIEW OF MENACWY-TT IMMUNOGENICITY AND SAFETY IN INFANTS.
Martinón-Torres F, Serra L, Safadi MAP.
Expert Rev Vaccines
Factor de impacto:
Q2
Doi:
PATHWAY TOWARDS AN IDEAL AND SUSTAINABLE FRAMEWORK AGREEMENT FOR THE PUBLIC PROCUREMENT OF VACCINES IN SPAIN: A MULTI-CRITERIA DECISION ANALYSIS.
Zozaya González N, Alcalá Revilla B, Arrazola Martínez P, Chávarri Bravo JR, Cuesta Esteve I, García Rojas A, Martinón-Torres F, Redondo Margüello E, Rivero Cuadrado A, Tamames Gómez S, Villaseca Carmena J, Hidalgo-Vega A
Hum Vaccine Immunother
Factor de impacto:
Q2
Doi:
WHOLE-EXOME SEQUENCING FOR THE IDENTIFICATION OF RARE VARIANTS IN PRIMARY IMMUNODEFICIENCY GENES IN CHILDREN WITH SEPSIS - A PROSPECTIVE POPULATION-BASED COHORT STUDY
Alessandro Borghesi, Johannes Trück, Samira Asgari, Vanessa Sancho-Shimizu, Philipp KA Agyeman, Evangelos Bellos, Eric Giannoni, Martin Stocker, Klara M Posfay-Barbe, Ulrich Heininger, Sara Bernhard-Stirnemann, Anita Niederer-Loher, Christian R Kahlert, Giancardlo Natalucci, Christa Relly, Thomas Riedel, Claudia E Kuehni, Christian W. Thorball, Nimisha Chaturvedi, Federico Martinon-Torres, Taco W Kuijpers, Lachlan Coin, Victoria Wright, Jethro Herberg, Michael Levin, Christoph Aebi, Christoph Berger, Jacques Fellay, Luregn J Schlapbach, for the EUCLIDS consortium and the Swiss Paediatric Sepsis Study
Clin Infect Dis
Factor de impacto:
Q1
Doi:
Links
Department of pediatricsGenCovidNanostringNextSeq
Legal noticePrivacy policy
Genvip 2023® – All rights reserved